Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy
Status:
Suspended
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
This study is an open-label, randomised, titration-blinded, parallel arm, multicenter study
to compare twice daily Chronocort® with standard care in participants with Congenital Adrenal
Hyperplasia (CAH). This study will be conducted in the USA.